221 related articles for article (PubMed ID: 12445563)
1. Enhanced transdermal delivery of triprolidine from the ethylene-vinyl acetate matrix.
Shin SC; Lee HJ
Eur J Pharm Biopharm; 2002 Nov; 54(3):325-8. PubMed ID: 12445563
[TBL] [Abstract][Full Text] [Related]
2. Transdermal delivery of triprolidine using TPX polymer membrane.
Shin SC; Kim J; Yoon MK; Oh IJ; Choi JS
Int J Pharm; 2002 Mar; 235(1-2):141-7. PubMed ID: 11879749
[TBL] [Abstract][Full Text] [Related]
3. Enhanced efficacy of triprolidine by transdermal application of the EVA matrix system in rabbits and rats.
Shin SC; Choi JS
Eur J Pharm Biopharm; 2005 Sep; 61(1-2):14-9. PubMed ID: 16005195
[TBL] [Abstract][Full Text] [Related]
4. Enhanced transdermal delivery of atenolol from the ethylene-vinyl acetate matrix.
Cho CW; Shin SC
Int J Pharm; 2004 Dec; 287(1-2):67-71. PubMed ID: 15541913
[TBL] [Abstract][Full Text] [Related]
5. Enhanced transdermal controlled delivery of glimepiride from the ethylene-vinyl acetate matrix.
Cho CW; Choi JS; Yang KH; Shin SC
Drug Deliv; 2009 Aug; 16(6):320-30. PubMed ID: 19606946
[TBL] [Abstract][Full Text] [Related]
6. Antihistamine effects of triprolidine from the transdermal administration of the TPX matrix in rats.
Shin SC; Choi JS
Arch Pharm Res; 2005 Jan; 28(1):111-4. PubMed ID: 15742818
[TBL] [Abstract][Full Text] [Related]
7. Controlled release of triprolidine using ethylene-vinyl acetate membrane and matrix systems.
Shin SC; Lee HJ
Eur J Pharm Biopharm; 2002 Sep; 54(2):201-6. PubMed ID: 12191692
[TBL] [Abstract][Full Text] [Related]
8. Development and biopharmaceutical evaluation of quinupramine-EVA matrix containing penetration enhancer for the enhanced transdermal absorption in rats.
Shin SC; Kim J; Kim WJ; Kim SJ; Cho CW
Pharm Dev Technol; 2007; 12(5):429-36. PubMed ID: 17963142
[TBL] [Abstract][Full Text] [Related]
9. Enhanced transdermal delivery of loratadine from the EVA matrix.
Cho CW; Choi JS; Kim SJ; Shin SC
Drug Deliv; 2009 May; 16(4):230-5. PubMed ID: 19514983
[TBL] [Abstract][Full Text] [Related]
10. Enhanced transdermal absorption and pharmacokinetic evaluation of pranoprofen-ethylene-vinyl acetate matrix containing penetration enhancer in rats.
Cho CW; Choi JS; Yang KH; Shin SC
Arch Pharm Res; 2009 May; 32(5):747-53. PubMed ID: 19471890
[TBL] [Abstract][Full Text] [Related]
11. Transdermal delivery of nicardipine: an approach to in vitro permeation enhancement.
Aboofazeli R; Zia H; Needham TE
Drug Deliv; 2002; 9(4):239-47. PubMed ID: 12511202
[TBL] [Abstract][Full Text] [Related]
12. Enhanced bioavailability of triprolidine from the transdermal TPX matrix system in rabbits.
Shin SC; Choi JS
Int J Pharm; 2002 Mar; 234(1-2):67-73. PubMed ID: 11839438
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of skin permeation of bufalin by limonene via reservoir type transdermal patch: formulation design and biopharmaceutical evaluation.
Yang Z; Teng Y; Wang H; Hou H
Int J Pharm; 2013 Apr; 447(1-2):231-40. PubMed ID: 23467076
[TBL] [Abstract][Full Text] [Related]
14. Effect of penetration enhancers on the release and skin permeation of bupranolol from reservoir-type transdermal delivery systems.
Babu RJ; Pandit JK
Int J Pharm; 2005 Jan; 288(2):325-34. PubMed ID: 15620873
[TBL] [Abstract][Full Text] [Related]
15. Enhanced Controlled Transdermal Delivery of Ambroxol from the EVA Matrix.
Cho CW; Kim DB; Cho HW; Shin SC
Indian J Pharm Sci; 2012 Mar; 74(2):127-32. PubMed ID: 23325993
[TBL] [Abstract][Full Text] [Related]
16. Formulation and evaluation of limonene-based membrane-moderated transdermal therapeutic system of nimodipine.
Krishnaiah YS; Bhaskar P; Satyanarayana V
Drug Deliv; 2004; 11(1):1-9. PubMed ID: 15168785
[TBL] [Abstract][Full Text] [Related]
17. Percutaneous absorption enhancer applied to membrane permeation-controlled transdermal delivery of nicardipine hydrochloride.
Seki T; Sugibayashi K; Juni K; Morimoto Y
Drug Des Deliv; 1989 Jan; 4(1):69-75. PubMed ID: 2775447
[TBL] [Abstract][Full Text] [Related]
18. Enhanced Controlled Transdermal Delivery of Mexazolam Using Ethylene-vinyl Acetate.
Weon Cho C; Chul Shin S
Iran J Pharm Res; 2012; 11(1):3-12. PubMed ID: 25317180
[TBL] [Abstract][Full Text] [Related]
19. Enhanced bioavailability of atenolol by transdermal administration of the ethylene-vinyl acetate matrix in rabbits.
Shin SC; Choi JS
Eur J Pharm Biopharm; 2003 Nov; 56(3):439-43. PubMed ID: 14602188
[TBL] [Abstract][Full Text] [Related]
20. In-vitro release and transdermal fluxes of a highly lipophilic drug and of enhancers from matrix TDS.
Funke AP; Günther C; Müller RH; Lipp R
J Control Release; 2002 Jul; 82(1):63-70. PubMed ID: 12106977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
